What medication is recommended for treating persistent hiccups (singultus)?

Medication for Persistent Hiccups

For persistent hiccups, start with baclofen or gabapentin as first-line therapy, with metoclopramide and chlorpromazine held in reserve. This recommendation is based on the best available evidence from systematic reviews, though it's important to note that no high-quality randomized controlled trials exist to guide treatment 1.

First-Line Agents

Baclofen

• Dosing: Start low and titrate upward as needed
• Evidence: Supported by small randomized, placebo-controlled trials 1
• Advantages: Less likely to cause side effects during long-term therapy compared to neuroleptic agents 1
• Mechanism: GABA-B agonist that may interrupt the hiccup reflex arc

Gabapentin

• Dosing: 300 mg three times daily has shown effectiveness 2
• Evidence: Supported by observational data and case reports showing significant improvement 1, 2
• Advantages: Well-tolerated with minimal side effects, even in elderly patients with chronic hiccups 2
• Mechanism: Works on α-2-δ subunit of calcium channels, though exact mechanism for hiccup relief remains unclear

Second-Line Agents

Metoclopramide

• Dosing: 5-20 mg oral or IV 3
• Evidence: Supported by small randomized, placebo-controlled trials 1
• Advantages: Dual dopamine/5-HT3 receptor antagonist; strongest evidence among antiemetics for non-chemotherapy-related symptoms 4
• Considerations: Can be used as breakthrough therapy

Chlorpromazine

• Status: Only FDA-approved drug specifically for hiccups 5
• Dosing: 37.5 mg/day divided three times daily has shown effectiveness 6
• Evidence: Supported by observational data 1
• Caution: Higher risk of side effects (sedation, delirium) compared to baclofen and gabapentin, particularly in elderly or cognitively impaired patients 7

Alternative Considerations

When Standard Agents Fail

• Pregabalin: Emerging evidence for refractory cases, particularly perioperatively 8
• Levetiracetam: May be effective for post-traumatic brain injury hiccups when standard agents fail; complete resolution reported within 8 hours of IV loading 9
• Levosulpiride: 25 mg three times daily showed effectiveness in COVID-19-related persistent hiccups 7

Critical Management Principles

Always identify and treat the underlying cause first - this is the most effective management strategy 1. Common reversible causes include:

• Gastroesophageal reflux (trial of proton pump inhibitors may be appropriate) 1
• Medication-induced (tramadol, opioids) - discontinue offending agent 10
• Metabolic disturbances
• Gastric distension or obstruction

Common Pitfalls

1. Avoid chlorpromazine as first-line in elderly or cognitively impaired patients - risk of sedation and delirium outweighs benefits 7
2. Don't overlook drug-induced causes - tramadol and other opioids can trigger persistent hiccups; discontinuation may resolve symptoms 10
3. Consider neurological causes - persistent hiccups in certain populations (hemodialysis patients, post-TBI) warrant evaluation for CNS disorders including brainstem infarctions 6

Evidence Quality Note

The systematic reviews consistently emphasize that no adequately powered, well-designed trials exist for hiccup treatment 1, 5. Treatment selection should be individualized based on:

• Patient comorbidities
• Underlying etiology of hiccups
• Individual drug properties and side effect profiles
• Previous treatment responses

The combination of baclofen or gabapentin as first-line therapy represents the safest approach with the best risk-benefit ratio, reserving dopamine antagonists for refractory cases 1.